XML 43 R32.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 28, 2026
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the three-month period ended March 28, 2026 was as follows:

 

   Shares   Weighted Average
Grant-Date Fair Value
   Grant-Date
Fair Value
 
Non-vested at December 27, 2025   5,339,847   $1.41   $7,551,683 
Granted   1,320,773    2.45   $3,234,760 
Forfeited   (55,950)   (1.28)  $(71,763)
Vested          $ 
Non-vested at March 28, 2026   6,604,670   $1.62   $10,714,680 
Expected to vest   6,604,670   $1.62   $10,714,680 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock and stock options awards for the three months ended March 28, 2026 and March 29, 2025 (no tax benefits were recognized):

 

   Three Months Ended   Three Months Ended 
   March 28, 2026   March 29, 2025 
Cost of product revenues  $50,008   $139,437 
Research and development   137,346    117,720 
Selling, general and administrative   307,974    517,235 
Total  $495,328   $774,392 
SCHEDULE OF STOCK OPTIONS WEIGHTED AVERAGE OF ASSUMPTIONS

The fair value of this options award was estimated using the Black-Scholes model using the following assumptions and had the following fair values:

 

   Three Months Ended 
   March 28, 2026 
Average risk-free interest rate   4.00%
Expected dividend yield   None 
Expected life (average, in years)   8.00 
Expected volatility   90.00%
Weighted average exercise price  $3.21 
Weighted average fair value  $2.07 
SUMMARY OF STOCK OPTION ACTIVITY

A summary of stock option activity for the period ended March 28, 2026 is as follows:

 

   Number of Options   Weighted Average Exercise Price   Intrinsic Value 
Outstanding as of December 27, 2025   591,366   $1.76   $366,647 
Granted   724,638   $3.21     
Outstanding as of March 28, 2026   1,316,004   $2.56   $ 
Options exercisable as of March 28, 2026   230,092   $2.05   $